Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #550

    It is not surprising that daratumumab is currently under evaluation in both other hematologic
    malignancies (acute lymphoblastic lymphoma, acute myeloid leukemia, non-Hodgkin lymphoma), as well
    as bladder and renal cell carcinoma previously treated with PD-1/PD-L1 antibodies.

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #551

      If ongoing
      trials show activity in these respective indications the use of the drug will only grow, further stressing
      health care resources in many areas. Additionally, limiting cancer patients’ time in busy infusion clinics
      will decrease their potential exposure to current and future pathogens of which they are inherently
      vulnerable, and at risk for more serious complications if infected. It would be reasonable to envision a

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #552

        future where forthcoming clinical trials use the subcutaneous formulation rather than traditional daraIV. For these reasons, and assuming FDA/EHA approval in the near future, we support the use of dara-SC
        for both standard of care and investigational use moving forward.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #553

          -end-

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #554

            Super. 😄

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #555

              I noticed: "... as well as bladder and renal cell carcinoma previously treated with PD-1/PD-L1 antibodies." A solid study we haven't heard of? Or one of the BMS studies?

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #556

                Could be this one : https://www.clinicaltrials.gov/ct2/show/NCT03473730

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #557

                  could be, it wasn't mentioned in the Genmab investor presentation

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #558

                    FDA grants Breakthrough Therapy Designation for Roche’s CD20xCD3 bispecific cancer immunotherapy mosunetuzumab recognising its potential in follicular lymphoma

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      GeorgeBest
                      wrote on sidst redigeret af
                      #559

                      FDA grants Breakthrough Therapy Designation for Roche’s CD20xCD3 bispecific cancer immunotherapy mosunetuzumab recognising its potential in follicular lymphoma

                      This designation is based on results from the phase I/Ib GO29781 study that showed mosunetuzumab demonstrated high response rates and durable complete remissions in people with relapsed or refracto...

                      favicon

                      (www.roche.com)

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #560

                        Roche er bare dygtige.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #561

                          Abbvie/Genmab har virkelig en hård konkurrent. Håber at data gør det hårde arbejde for dem !

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #562

                            Flot rebound af Genmab. NOVO og ZEAL bliver stående på perronen. 🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              B.Andersen
                              wrote on sidst redigeret af
                              #563

                              Det holdt nu ikke mange timer.

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #564

                                Hvornår er det JJ har regnskab, er det 16/7?

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #565

                                  Mcjean...du tjekker bare her. https://www.proinvestor.com/chathistory/-120/finanskalender 🙂

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    Mcjean
                                    wrote on sidst redigeret af
                                    #566

                                    Har fundet det super, tak Helge for din nye informationside

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #567

                                      Velbekommen. 🙂

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Stroka
                                        wrote on sidst redigeret af
                                        #568

                                        Hvem trak bundproppen ud?

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Klarussen
                                          wrote on sidst redigeret af
                                          #569

                                          Bliver interessant om bunden i trendkanalen fra midtmarts holder...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger